DTx Product Profile

Daylight®

Daylight helped 71% of patients achieve clinical improvement in anxiety.

Product Highlight

Condition targeted:

Generalized anxiety disorder

How it works:

Daylight is a digital therapeutic for managing anxiety. It’s based on proven cognitive behavioral therapy and is developed by clinical psychologists and researchers. By spending just 10 minutes per day with Daylight’s structured, responsive program, you could see improvements within a few weeks – in trials, 71% of participants recovered from clinical levels of anxiety in 10 weeks.

Impact:

Daylight helped 71% of patients achieve clinical improvement in anxiety.

Overview

Medical condition:

Generalized anxiety disorder

Target patient population:

Patients who desire lasting recovery from anxiety

What to expect:

Daylight helped 71% of patients achieve clinical improvement in anxiety.

Clinical Overview

Indications for use:

Daylight is a digital therapeutic intended for the improvement of worry and anxiety and the management of Generalized Anxiety Disorder (GAD) in adults aged 18 years and older, as an adjunct to their usual medical care. For adults diagnosed with GAD, Daylight should be used under the supervision of a healthcare professional. For otherwise healthy adults who have difficulty with worry and anxiety, Daylight may be used as a non-prescription self-help tool to improve overall mental health and wellbeing.

Outcomes:

Daylight helped 71% of patients achieve clinical improvement in anxiety.

Directions:

Users can spend as little as 10 minutes per day with Daylight’s structured, guided techniques, and see improvements within weeks. Daylight’s lessons can be paused or restarted by the user whenever needed.

Through this 10 minute per day commitment, users will build life-long skills to reduce tension, re-frame anxious thoughts, and develop helpful behaviors. And Daylight keeps the user on track by giving suggestions based on their individual needs, and checking in with them to guide progress.

Risks & warnings:

Daylight may not be suitable for people without internet, wifi, or a mobile device. Daylight is a digital therapeutic intended for the improvement of worry and anxiety and the management of generalized anxiety disorder (GAD) in adults aged 18 years and older, as an adjunct to their usual medical care.

Place in therapy:

Complimentary to current therapy and effective as a standalone solution.

Product Access

Product description:

Daylight is a digital therapeutic for managing anxiety. It’s based on proven cognitive behavioral therapy and is developed by clinical psychologists and researchers. By spending just 10 minutes per day with Daylight’s structured, responsive program, you could see improvements within a few weeks – in trials, 71% of participants recovered from clinical levels of anxiety in 10 weeks.

Prescription status:

No prescription is required.

Patient access:

Eligible users can download the Daylight app on iOS or Android devices.

Use of this product requires access to:

Provider access:

Daylight provides a non-drug alternative for anxiety without needing a prescription. In the UK, Daylight is available for eligible individuals through self-referral or by visiting their GP.

Coverage options:

In the US, Daylight is offered through large payers including self-insured employers. Daylight is offered to millions of people in the UK through their NHS services.

Product availability:

Daylight is available in:

Unique Features.

Through a strategic collaboration with CVS, Big Health pioneered billing through the PBM, which allows people to pay for digital therapeutics in a similar way to how they pay for drugs.

Clinical Trials

Copyright © 2021 Digital Therapeutics Alliance™